Lizton, IN, United States of America

Nancy June Snyder

This inventor holds 19 USPTO granted patents and 3 published patent applications, plus 1 CIPO patent and 10 EPO patents, primarily in Peptidomimetic Inhibitors. Top assignees: Eli Lilly and Company, Vertex Pharmaceuticals, Inc., Other. Active years: 1993-2013.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Nancy June Snyder. Retrieved from https://idiyas.com/inventor/nancy-june-snyder

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 19 

% Patents Active = 42.1


 

Average Co-Inventor Count = 4.8

ph-index = 9

Forward Citations = 221(Granted Patents)


Location History:

  • Boston, PA (US) (1993)
  • Charlottesville, IN (US) (1998 - 1999)
  • Parsippany, NJ (US) (2003)
  • Lizton, IN (US) (2006 - 2013)

Company Filing History:


Years Active: 1993-2013

Loading Chart...
Loading Chart...
Loading Chart...
Areas of Expertise:
Peptidomimetic Protease Inhibitors
11-Beta-Hydroxysteroid Dehydrogenase
Biphenyl Amide Lactam Derivatives
Cyclohexyl Substituted Pyrrolidinones
Cyclohexylpyrazole-Lactam Derivatives
MCH Receptor Antagonists
Multicyclic Compounds
Glycopeptide Antibiotic Derivatives
Thermal Insulation Installation
Traction Tube Holder
19 patents (USPTO):Explore Patents

Title: Nancy June Snyder: A Pioneering Inventor in Hepatitis C Research

Introduction

Nancy June Snyder, an innovative inventor based in Lizton, IN, has made significant contributions to the field of medical science through her impressive portfolio of 17 patents. Her work primarily focuses on the development of peptidomimetic compounds, which hold promise in the fight against hepatitis C.

Latest Patents

Among her latest inventions, Nancy has developed peptidomimetic protease inhibitors, specifically designed to serve as serine protease inhibitors against the hepatitis C NS3 protease. Her inventive approach involves novel stereoselective processes leading to key intermediates, which form the backbone of her pharmaceutical compositions. These compounds are essential for inhibiting the HCV protease, offering new methods for treating patients suffering from hepatitis C infection and related physiological conditions. Furthermore, her inventions include pharmaceutical kits and packs designed for treating HCV infections, showcasing her dedication to improving patient outcomes.

Career Highlights

Throughout her career, Nancy has worked with esteemed organizations such as Eli Lilly and Company and Vertex Pharmaceuticals, Inc. Her experience in these prominent companies has contributed to her expertise in developing cutting-edge pharmaceutical innovations that address critical healthcare challenges.

Collaborations

Nancy has collaborated with notable professionals in the industry, including Owen Brendan Wallace and Yanping Xu. Their joint efforts have advanced research and development in the area of protease inhibitors, further establishing Nancy's reputation as a leading inventor in her field.

Conclusion

Nancy June Snyder's contributions to medical science, particularly in the area of hepatitis C treatment, have established her as a significant figure among inventors. Her extensive patent portfolio and collaborations with esteemed colleagues reflect her commitment to innovation and her role in shaping future medical therapies.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…